Matteo Foschi Shares Review on Ischemic Stroke Despite Appropriate Oral Anticoagulation
Matteo Foschi, Neurologist at Azienda USL della Romagna, shared on LinkedIn:
”Our systematic review and meta-analysis on ischemic stroke despite appropriate oral anticoagulation is now published in Neurological Sciences Springer Nature
Across 10,624 patients, we found:
• a high burden of vascular risk factors,
• moderate stroke severity,
• and better 90-day functional outcomes with DOACs vs VKAs (60.4% vs 35.7%).
Despite guideline-recommended OAC, stroke still occurs — and major knowledge gaps persist regarding mechanisms and long-term prognosis.
This is exactly the space the ASPERA Registry is designed to fill, and the first ASPERA papers will emerge soon.”
Read the full article here.
Article: Clinical characteristics and outcomes of ischemic stroke despite appropriate oral anticoagulation for atrial fibrillation: A systematic review and meta-analysis of real-world studies
Authors: Francesca Gabriele, Federico De Santis, Maria Grazia Vittorini, Lucio D’Anna, Giovanni Merlino, Francesco Bax, Raffaele Ornello, Simona Sacco, Matteo Foschi

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning
-
Oct 9, 2026, 14:07Chokri Ben Lamine: Pain After Allogeneic Stem Cell Transplantation in Sickle Cell Disease
-
Oct 9, 2026, 13:55Chandler Purser: AABB 2026 Focuses on Transfusion Safety and Audit-Driven Practice Improvement
-
Oct 9, 2026, 13:48Maxime Dely: Raising Awareness for Blood Donation
-
Oct 9, 2026, 13:48Vera Ghali: Anemia in Myelofibrosis and Its Impact on Treatment Outcomes and Overall Survival
-
Oct 9, 2026, 13:32W David Freeman։ The Mechanical Penumbra in Intracerebral Hemorrhage and Its Potential for Tissue Recovery
-
Oct 9, 2026, 13:11Ayshathul Noora։ Carbetocin vs Oxytocin in Preventing Postpartum Hemorrhage
-
Oct 9, 2026, 13:07The Rebalanced Patient: New Therapies and New Thrombotic Risks in Hemophilia